Vir Biotechnology Inc. (VIR)
NASDAQ: VIR
· Real-Time Price · USD
5.58
-0.05 (-0.89%)
At close: May 07, 2025, 10:28 AM
-0.89% (1D)
| Bid | 5.58 |
| Market Cap | 771.09M |
| Revenue (ttm) | 73.11M |
| Net Income (ttm) | -521.96M |
| EPS (ttm) | -3.83 |
| PE Ratio (ttm) | -1.46 |
| Forward PE | -1.84 |
| Analyst | Buy |
| Ask | 5.59 |
| Volume | 135,859 |
| Avg. Volume (20D) | 1,221,438 |
| Open | 5.61 |
| Previous Close | 5.63 |
| Day's Range | 5.54 - 5.67 |
| 52-Week Range | 4.95 - 14.45 |
| Beta | 1.36 |
Analyst Forecast
According to 0 analyst ratings, the average rating for VIR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Vir Biotechnology Inc. is scheduled to release its earnings on May 7, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+58.17%
Vir Biotechnology shares are trading higher after ...
Unlock content with
Pro Subscription
6 months ago
+23.63%
Vir Biotechnology shares are trading higher. The company reported Q3 financial results.
2 months ago · businesswire.com
Vir Biotechnology to Participate in TD Cowen 45th Annual Health Care ConferenceSAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that members of the executive team are scheduled to participate in a fireside chat at the TD Cowen 45th Annual Hea...